Abbott Laboratories and the FDA have agreed on a roadmap to open its troubled baby formula plant.
Abbott Laboratories and the FDA have agreed on a roadmap to open its troubled baby formula plant, but the company says it will be more than a month before the move can have any effect on the market.
The closure of the Abbott formula plant in Sturgis, Mich., contributed to a nationwide shortage of infant formula that has reached crisis proportions. The plant was closed down in February after evidence of microbial contamination was discovered there.
On May 16, the FDA and Abbott announced a consent decree to get the plant up and running. The plant could resume operations in two weeks if a court approves, although Abbott issued a statement saying it would be six to eight weeks before new supplies of Similac and other products would reach retail shelves.
The FDA also confirmed on Monday that it is relaxing regulations to allow easier imports of baby formula from overseas. Nestlé announced that it would fly extra shipments of formula into the U.S. from Switzerland and Holland.
Kaeser is the world’s leading air systems specialist and offers a full range of compressed air solutions for almost any application. From industrial compress...
Take a moment to see the scope of Kaeser's commitment to innovative system designs that guarantee ultra-reliable compressed air, easy maintenance, and greater efficiency.
Ventilation has a huge impact on the ambient temperature in the compressor room and is often the missing link to temperature regulation issues. Here are four factors to consider...
Learn how to get a smart, reliable, energy-efficient compressed air system delivered in a turnkey, weatherproof and temperature-controlled enclosure that needs little or no onsite...
